Toggle navigation
E
ncyclo
R
eader
Preferences
About
Help
Categories
Immunomodulating drugs
Immunosuppressants
Topic: Category
From
Wikipedia
- Reading time: 4 min
v
t
e
Immunosuppressive drugs
/
Immunosuppressants
(
L04
)
Intracellular
(initiation)
Antimetabolites
purine synthesis inhibitors
Azathioprine
Mycophenolic acid
dihydroorotate dehydrogenase
inhibitors
Leflunomide
Teriflunomide
antifolate
Methotrexate
Macrolides
/
other
IL-2
inhibitors
FKBP
/
Cyclophilin
/
Calcineurin
Ciclosporin
Pimecrolimus
Tacrolimus
Voclosporin
Abetimus
Gusperimus
IMiDs
Lenalidomide
Pomalidomide
Thalidomide
PDE4 inhibitor
Apremilast
Intracellular
(reception)
IL-1 receptor antagonists
Anakinra
mTOR
Everolimus
Ridaforolimus
Sirolimus
Temsirolimus
Umirolimus
Zotarolimus
Extracellular
Antibodies
Monoclonal
Serum target
(noncellular)
Complement component 5
Eculizumab
TNF
Adalimumab
Afelimomab
Certolizumab pegol
Golimumab
Infliximab
Nerelimomab
Interleukin
Anakinra
Basiliximab
Bimekizumab
Briakinumab
Brodalumab
Canakinumab
Daclizumab
Guselkumab
Ixekizumab
Netakimab
Olokizumab
Rilonacept
Risankizumab
Sarilumab
Satralizumab
Secukinumab
Siltuximab
Sirukumab
Spesolimab
Tildrakizumab
Tocilizumab
Ustekinumab
Interleukin 5
Mepolizumab
Immunoglobulin E
Omalizumab
Interferon
Faralimomab
IL-6
Elsilimomab
IL-12
,
IL-13
, and
IL-23
Lebrikizumab
Ustekinumab
IL-17A
Secukinumab
Cellular
target
CD3
Muromonab-CD3
Otelixizumab
Teplizumab
Visilizumab
CD4
Clenoliximab
Keliximab
Zanolimumab
CD11a
Efalizumab
CD18
Erlizumab
CD20
Obinutuzumab
Ocrelizumab
(
+hyaluronidase
)
Pascolizumab
Rituximab
Ublituximab
CD23
Gomiliximab
Lumiliximab
CD40
Teneliximab
Toralizumab
CD62L/L-selectin
Aselizumab
CD80
Galiximab
CD147/Basigin
Gavilimomab
CD154
Frexalimab
Ruplizumab
BLyS
Belimumab
CAT
Bertilimumab
Lerdelimumab
Metelimumab
Integrin
Natalizumab
Vedolizumab
Interleukin-6 receptor
Tocilizumab
LFA-1
Odulimomab
IL-2 receptor/CD25
Basiliximab
Daclizumab
Inolimomab
T-lymphocyte
(
Zolimomab aritox
)
Unsorted
Alemtuzumab
Anifrolumab
Atorolimumab
Begelomab
Cedelizumab
Emapalumab
Fontolizumab
Inebilizumab
Maslimomab
Morolimumab
Ofatumumab
Pexelizumab
Reslizumab
Rovelizumab
Siplizumab
Talizumab
Telimomab aritox
Teprotumumab
Vapaliximab
Vepalimomab
Polyclonal
Anti-thymocyte globulin
Anti-lymphocyte globulin
-cept (
Fusion
)
CTLA-4
Abatacept
Belatacept
TNF inhibitor
Etanercept
Opinercept
Aflibercept
Alefacept
Rilonacept
Unsorted
Avacopan
Baricitinib
Bimekizumab
Blisibimod
Briakinumab
Brodalumab
Canakinumab
Crovalimab
Danicopan
Darvadstrocel
Deucravacitinib
Deuruxolitinib
Dimethyl fumarate
Diroximel fumarate
Efgartigimod alfa
(
+hyaluronidase
)
Etrasimod
Filgotinib
Fingolimod
Guselkumab
Iptacopan
Itacitinib
Ixekizumab
Netakimab
Olokizumab
Ozanimod
Peficitinib
Pegcetacoplan
Pirfenidone
Ponesimod
Ravulizumab
Risankizumab
Ritlecitinib
Rozanolixizumab
Sarilumab
Satralizumab
Siltuximab
Siponimod
Sirukumab
Spesolimab
Sutimlimab
Telitacicept
Tildrakizumab
Tofacitinib
Upadacitinib
This category reflects the organization of
Anatomical Therapeutic Chemical Classification System
code
L04
.
Generally, drugs outlined within the
ATC code L04
should be included in this category.
Please see
WP:PHARM:CAT
for more information.
Wikimedia Commons has media related to
Immunosuppressants
.
Licensed under CC BY-SA 3.0 | Source:
https://en.wikipedia.org/wiki/Category:Immunosuppressants
8 views | ↧
Download as ZWI file